Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Epilepsy Research
|
April 20, 2012
Retigabine as adjunctive therapy in adults with partial-onset seizures: integrated analysis of three pivotal controlled trials
Roger J Porter, David E Burdette, Antonio Gil-Nagel, et al.
Epilepsy & Behavior : E&B
|
March 1, 2003
The nature of aggression during epileptic seizures
Antonio V. Delgado-Escueta, Richard H. Mattson, Lambert King, et al.
Epilepsia Open
|
March 7, 2025
Interim analysis of the long-term efficacy and safety of azetukalner in an ongoing open-label extension study following a phase 2b clinical trial (X-TOLE) in adults with focal epilepsy
Jacqueline A French, Roger J Porter, Emilio Perucca, et al.
Epilepsy & Behavior : E&B
|
July 4, 2025
Brivaracetam effectiveness and patient-reported outcomes in clinical practice: Data from a 12-month prospective, observational study in the United States
Hina Dave, Michael R Sperling, Hamada Hamid Altalib, et al.
JAMA Neurology
|
October 9, 2023
Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy: A Phase 2b Randomized Clinical Trial
Jacqueline A French, Roger J Porter, Emilio Perucca, et al.
Epilepsia
|
August 6, 2013
Development of new treatment approaches for epilepsy: unmet needs and opportunities
Jacqueline A French, H Steve White, Henrik Klitgaard, et al.
Epilepsia
|
August 6, 2013
Issues related to development of new antiseizure treatments
Karen S Wilcox, Tracy Dixon-Salazar, Graeme J Sills, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Epilepsy Research
|
April 20, 2012
Retigabine as adjunctive therapy in adults with partial-onset seizures: integrated analysis of three pivotal controlled trials
Roger J Porter, David E Burdette, Antonio Gil-Nagel, et al.
Epilepsy & Behavior : E&B
|
March 1, 2003
The nature of aggression during epileptic seizures
Antonio V. Delgado-Escueta, Richard H. Mattson, Lambert King, et al.
Epilepsia Open
|
March 7, 2025
Interim analysis of the long-term efficacy and safety of azetukalner in an ongoing open-label extension study following a phase 2b clinical trial (X-TOLE) in adults with focal epilepsy
Jacqueline A French, Roger J Porter, Emilio Perucca, et al.
Epilepsy & Behavior : E&B
|
July 4, 2025
Brivaracetam effectiveness and patient-reported outcomes in clinical practice: Data from a 12-month prospective, observational study in the United States
Hina Dave, Michael R Sperling, Hamada Hamid Altalib, et al.
JAMA Neurology
|
October 9, 2023
Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy: A Phase 2b Randomized Clinical Trial
Jacqueline A French, Roger J Porter, Emilio Perucca, et al.
Epilepsia
|
August 6, 2013
Development of new treatment approaches for epilepsy: unmet needs and opportunities
Jacqueline A French, H Steve White, Henrik Klitgaard, et al.
Epilepsia
|
August 6, 2013
Issues related to development of new antiseizure treatments
Karen S Wilcox, Tracy Dixon-Salazar, Graeme J Sills, et al.
Page
of 2